Evidence map›Paper›PMID 38507175›Full record

ArticleUpdates in surgery2024

Gastrointestinal histoplasmosis with small intestinal perforation: 20-year experience.

Jack W Sample, Jennifer A Yonkus, Maxwell D Mirande, Rondell P Graham, Scott R Kelley

Abstract read
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jack W SampleDepartment of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. sample.jack@mayo.edu.ORCID http://orcid.org/0000-0002-1837-0291
Jennifer A YonkusDepartment of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-9915-6184
Maxwell D MirandeDepartment of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-2736-9452
Rondell P GrahamDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-8686-4867
Scott R KelleyDivision of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-1390-0019

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postmortem studies show gastrointestinal tract involvement in as many as 70% of patients affected by disseminated histoplasmosis. Although gastrointestinal involvement is common in disseminated disease, the presentation of small intestinal perforation is exceedingly rare with few reported cases in the literature. Herein we present our institutional case series. The aim of the study is to describe small intestinal perforation in gastrointestinal histoplasmosis with attention to management and outcomes. This is a retrospective single-institution review of patients ≥ 18 years of age treated for small intestinal perforation due to gastrointestinal histoplasmosis. A prospectively maintained institutional database was searched from 2002 to 2022. Data obtained included demographics, comorbidities, treatment course, and outcomes. Five patients with a mean age of 54 years (range 25-72) were identified. Pertinent underlying comorbid conditions included Crohn's disease, psoriatic arthritis, rheumatoid arthritis, and solid organ transplantation. All patients were on chronic immunosuppressive medication(s) with the most common being tumor necrosis factors alpha inhibitors and corticosteroids. Four had a clinical diagnosis of perforation based on physical examination and imaging. All patients underwent segmental resection(s) of the small intestine and received medical treatment with intravenous amphotericin B and eventual transition to an oral antifungal. No patients experienced complications related to surgery. The limitations of the study include nonrandomized retrospective review, single-institution experience, and small patient sample size. Although rare, histoplasmosis should be considered in the differential of patients on chronic immunosuppressive therapy who present with gastrointestinal symptoms concerning perforation, especially from endemic areas. Small intestinal perforation due to gastrointestinal histoplasmosis can be successfully treated with resection and antifungal therapy.

Indexed as

Antifungal AgentsHistoplasmosisIntestinal PerforationIntestine, SmallAdultAgedAmphotericin BFemaleHumansImmunosuppressive AgentsMaleMiddle AgedRetrospective StudiesTreatment OutcomeAmphotericin BAntifungal AgentsImmunosuppressive AgentsDisseminated histoplasmosisGastrointestinal histoplasmosisHistoplasmosisIntestinal perforation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.